STOCK TITAN

Genesco (NYSE: GCO) awards director 3,905 shares of restricted stock

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Bojanowski Carolyn reported acquisition or exercise transactions in this Form 4 filing.

Genesco Inc. director Carolyn Bojanowski received a grant of 3,905 shares of restricted common stock under the company’s Fourth Amended and Restated 2020 Equity Incentive Plan. The award carried a reported price of $0.00 per share, and she now directly holds 19,006 Genesco common shares.

Positive

  • None.

Negative

  • None.
Insider Bojanowski Carolyn
Role Director
Type Security Shares Price Value
Grant/Award Common Stock F1 3,905 $0.00 $0.00
Holdings After Transaction: Common Stock — 19,006 shares (Direct)
Footnotes (1)
  1. F1. Grant of restricted stock under the Fourth Amended and Restated 2020 Equity Incentive Plan.
Restricted stock granted 3,905 shares Grant of Genesco common stock to director Carolyn Bojanowski
Price per share $0.00 Reported grant price for the 3,905 restricted shares
Shares held after transaction 19,006 shares Total direct Genesco common shares held by Carolyn Bojanowski after the grant
Transaction date 2026-07-24 Date of restricted stock grant to the Genesco director
restricted stock financial
"Grant of restricted stock under the Fourth Amended and Restated 2020 Equity Incentive Plan"
Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.
Equity Incentive Plan financial
"under the Fourth Amended and Restated 2020 Equity Incentive Plan"
An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.
Grant, award, or other acquisition regulatory
"transaction code description: Grant, award, or other acquisition"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider stock transaction did Genesco (GCO) report for Carolyn Bojanowski?

Genesco director Carolyn Bojanowski received a grant of 3,905 restricted common shares. The award was made under the Fourth Amended and Restated 2020 Equity Incentive Plan and increased her direct holdings to 19,006 Genesco common shares in total.

How many Genesco (GCO) shares does Carolyn Bojanowski own after the latest grant?

After the reported equity award, Carolyn Bojanowski directly owns 19,006 shares of Genesco common stock. This total reflects the addition of 3,905 restricted shares granted to her as a director under Genesco’s Fourth Amended and Restated 2020 Equity Incentive Plan.

What type of equity did Genesco (GCO) grant to director Carolyn Bojanowski?

Carolyn Bojanowski received restricted common stock in Genesco. The grant consisted of 3,905 restricted shares issued under the company’s Fourth Amended and Restated 2020 Equity Incentive Plan, a stock-based compensation program used to award equity to eligible participants.

Was there a purchase price for Carolyn Bojanowski’s new Genesco (GCO) shares?

The grant to Carolyn Bojanowski was reported at a price of $0.00 per share, indicating a compensation-related award rather than an open-market purchase. She received 3,905 restricted shares of Genesco common stock as part of the company’s equity incentive program.

Under which plan was Carolyn Bojanowski’s Genesco (GCO) stock grant made?

The 3,905-share restricted stock award to Carolyn Bojanowski was granted under Genesco’s Fourth Amended and Restated 2020 Equity Incentive Plan. This plan governs stock-based compensation grants, including restricted stock, to directors and other eligible service providers of the company.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Bojanowski Carolyn

(Last)(First)(Middle)
C/O GENESCO INC.
535 MARRIOTT DRIVE

(Street)
NASHVILLE TENNESSEE 37214

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
GENESCO INC [ GCO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/24/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock07/24/2026A3,905(1)A$0.0019,006D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Grant of restricted stock under the Fourth Amended and Restated 2020 Equity Incentive Plan.
Scott E. Becker, Attorney-in-Fact07/24/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)